Literature DB >> 10834408

Impaired glucose tolerance: the irrepressible alpha-cell?

E Ipp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10834408     DOI： 10.2337/diacare.23.5.569

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  6 in total

1.  Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus.

Authors:  F K Knop; T Vilsbøll; S Madsbad; J J Holst; T Krarup
Journal:  Diabetologia       Date:  2007-01-16       Impact factor: 10.122

2.  Glucagon secretion in relation to insulin sensitivity in healthy subjects.

Authors:  B Ahrén
Journal:  Diabetologia       Date:  2005-12-17       Impact factor: 10.122

3.  Obesity dysregulates fasting-induced changes in glucagon secretion.

Authors:  Jennifer H Stern; Gordon I Smith; Shiuwei Chen; Roger H Unger; Samuel Klein; Philipp E Scherer
Journal:  J Endocrinol       Date:  2019-11       Impact factor: 4.286

4.  Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals.

Authors:  Jonatan I Bagger; Filip K Knop; Asger Lund; Jens J Holst; Tina Vilsbøll
Journal:  Diabetologia       Date:  2014-05-31       Impact factor: 10.122

Review 5.  Peroxisome proliferator-activated receptor-gamma agonists and diabetes: current evidence and future perspectives.

Authors:  Francesco Chiarelli; Daniele Di Marzio
Journal:  Vasc Health Risk Manag       Date:  2008

6.  Higher glucagon-to-insulin ratio is associated with elevated glycated hemoglobin levels in type 2 diabetes patients.

Authors:  Minyoung Lee; Minkyung Kim; Jong Suk Park; Sangbae Lee; Jihong You; Chul Woo Ahn; Kyung Rae Kim; Shinae Kang
Journal:  Korean J Intern Med       Date:  2017-09-08       Impact factor: 2.884
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.